While our study is underway, a most recent study employed TRPM7 knockdown approach for in vitro assays, and reported that TRPM7 knockdown dampened ovarian cancer cell glycolysis via AMPK activation and HIF1 degradation [25]. This evidence concerns the gene TRPM7 and ovarian cancer.